Evidence map›Paper›PMID 39541409›Full record

ReviewVirulence2024

Jiewen Wang, Buwei Wang, Jian Xiao, Yuqing Chen, Chuan Wang

Abstract readReview
In one paragraph

Review in Virulence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Pneumonia with BALF Detection ofInfection and drug resistance · 2026
    Article
  9. Article
  10. Article
  11. Antimicrobial Management of SevereInfection and drug resistance · 2026
    Review
  12. Article
  13. Article
  14. Kaempferol inhibitsFrontiers in microbiology · 2026
    Article
  15. Case Report: Coinfection ofFrontiers in medicine · 2026
    Article
  16. Article
  17. Clinical characterization ofFrontiers in medicine · 2026
    Article
  18. Article
  19. Clinical Features of 186 Cases ofInfection and drug resistance · 2026
    Article
  20. Clinical management and pharmaceutical care of severeFrontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiewen WangInstitute of Pathogenic Biology, School of Basic Medicine, Hengyang Medical College, University of South China; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.ORCID 0009-0005-3035-5421
Buwei WangInstitute of Pathogenic Biology, School of Basic Medicine, Hengyang Medical College, University of South China; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.
Jian XiaoThe Affiliated Nanhua Hospital, Department of laboratory medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Yuqing ChenClinical Microbiology Laboratory, Xiangtan Central Hospital, Xiangtan, Hunan, China.
Chuan WangInstitute of Pathogenic Biology, School of Basic Medicine, Hengyang Medical College, University of South China; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang, Hunan, China.ORCID 0000-0002-8743-9408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bird DiseasesBirdsChlamydophila psittaciPsittacosisZoonosesAnimalsBacterial ZoonosesGenotypeHost-Pathogen InteractionsHumansChlamydia psittacidetectionepidemiologyhost–pathogen interactiontransmissionzoonosis

Identifiers

PMID39541409
PMCPMC11622591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.